Überblick


Lionel Lesur focuses his legal practice primarily on the areas of corporate law, mergers and acquisitions and competition/distribution law.

Lionel advises domestic and international companies from a broad range of industries, including life sciences, fashion and luxury as well as investment funds and top managers. He has experience in the negotiation of mergers and acquisitions, leveraged buyouts, complex commercial contracts and in advising foreign companies seeking to establish themselves in France.

Mehr anzeigen

Ausgewählte Referenzmandate


  • Advised Swiss group Zur Rose on its acquisition of Doctipharma
  • Advised Swiss company Sophia Genetics on its acquisition of Interactive Biosoftware
  • Advised Canadian company LuminUltra Technologies on its acquisition of the business concerns of ATP-Métrie U
  • Advised American biotech company Akcea Therapeutics on its greenfield implementation in France and in Europe

Mehr anzeigen

Auszeichnungen


  • The Best Lawyers in France, 2021
  • Option Droit & Affaires 2018, Recommended
  • Who’s Who Legal: Competition, Future Leaders 2017
  • Décideurs Juridiques 2016, Antitrust & Competition, Merger Control, Highly Recommended

Mehr anzeigen

Mitgliedschaften


  • Club des Juristes
  • Aristoclès
  • International Bar Association (French-Italian Day)

Mehr anzeigen

Qualifikation


Education
HEC Paris School of Management,
Master in Science of Management, 2005
Community of European Management School, Master’s, International Management, 2005
University of Paris-Nanterre, LLM (DEA), European and International Business Law, 2001
University of Paris XI – Sceaux, LLM (DESS), Business Law, 2000
University of Paris II Panthéon-Assas, Maîtrise, Tax and Business law, 1999

Mehr anzeigen

Lionel Lesur

Einblicke & Events / Medien

M&A Review, Volume 30 / September 2, 2019

Special Report / 18. February 2019

Special Report / Januar 2017

On the Subject / February 27, 2014

Magazine des Affaires / February - March, 2014

Décideurs stratégies finance droit - Risk Management, Assurance & Contentieux / February - March, 2014

1

2

3

4

5

6

7

... 7